BMY - Mirati Therapeutics could see another bidder emerge Leerink says
2023-10-09 09:56:59 ET
More on Mirati Therapeutics
- Mirati: Expansion Of Adagrasib With sNDA And Combination Studies
- Mirati Therapeutics, Inc. 2023 Q2 - Results - Earnings Call Presentation
- Mirati Therapeutics, Inc. (MRTX) Q2 2023 Earnings Call Transcript
- 4 stocks to watch on Monday: Mirati Therapeutics, Arm Holdings and more
- Bristol-Myers Squibb to acquire Mirati Therapeutics for $4.8B
For further details see:
Mirati Therapeutics could see another bidder emerge, Leerink says